Switzerland’s Covid-19 scientific taskforce chief says hospitals across the Alpine country could be swamped with new coronavirus cases in the next two or three weeks unless the situation improves.
“We estimate that the capacity limit in intensive care in hospitals will be reached between November 5-18 if nothing changes from the current situation,” Martin Ackermann told reporters in Bern on Friday. “We don’t have time to wait any longer.”
The number of new Covid-19 cases has risen sharply in recent days. A total of 6,634 new cases – a record – were reported by the Swiss health authorities on Friday.
They confirmed that the country was now more badly affected than its neighbours: it now has 495 cases per 100,000 inhabitants. Only France approaches these levels at 450 cases per 100,000.
On Friday, Ackermann said that hospitalisations were doubling week by week. The same goes for the number of intensive care cases and deaths due to Covid-19. Over the past 14 days 689 people were hospitalised, and 75 died.
Overall, there have now been more than 100,000 cases – 103,653 cases to be precise – since the start of the epidemic and 1,877 deaths.
Contact to a minimum
He urged people to keep their contact with others to a minimum, while the head of the association of cantonal doctors asked people to avoid “delicate situations”, by keeping to social distancing and avoid risky sports and leisure activities.
Testing and tracing capacity is stretched, with officials appealing to those who test positive to personally inform people with whom they have had contact.
Ackermann told reporters that Switzerland’s containment strategy was no longer working due to the high number of cases. For the virus reproduction rate to drop below 1 again, it is necessary to reduce professional and private contacts by half, he said.
The University of Oxford, in collaboration with AstraZeneca plc, today announces interim trial data from its Phase III trials that show its candidate vaccine, ChAdOx1 nCoV-2019, is effective at preventing COVID-19 (SARS-CoV-2) and offers a [...]
A genetic modification in the ‘coat’ of a brain infection-causing virus may allow it to escape antibodies, according to Penn State College of Medicine researchers. They say testing people for this and other viral mutations [...]
Current chemotherapy regimens slow cancer progression and save lives, but these powerful drugs affect both healthy and cancerous cells. Now, researchers reporting in ACS' Nano Letters have designed DNA-based nanogels that only break down and [...]
The new technology behind Pfizer's and Moderna's coronavirus vaccines could be used to prevent everything from heart disease to cancer, experts say. The breakthrough vaccine 'platform' they use transforms the body into a virus-zapping vaccine [...]
Current state-of-the-art techniques have clear limitations when it comes to imaging the smallest nanoparticles, making it difficult for researchers to study viruses and other structures at the molecular level. Scientists from the University of Houston [...]
Virtual patients, vaccines, medicine-making biomachines and microneedles are examples of tech innovation that is meeting the moment to address the global health crisis. Health has been a strong focus for this year’s top 10 [...]
A Vancouver company is central to the news Monday morning that Pfizer is close to developing an effective vaccine against the coronavirus. Pfizer said Monday that an early peek at the data on its [...]
The first coronavirus vaccine can prevent more than 90% of people from getting Covid-19, a preliminary analysis shows. The developers - Pfizer and BioNTech - described it as a "great day for science and humanity". [...]
Researchers led by the University at Buffalo (UB) have devised a new method that could enhance the effectiveness of vaccines against the novel coronavirus, the virus that is responsible for causing COVID-19. Jonathan F. Lovell, PhD, an [...]
On March 17 this year, a man was taken to hospital in Israel suffering from a dry cough and a loss of sense of smell. He developed a fever and felt tired but, after three [...]
One of the world’s leading Covid-19 experimental vaccines produces an immune response in older adults as well as the young, its developers say, raising hopes of protection for those most vulnerable to the coronavirus that [...]
Coronavirus tests performed in labs are the gold standard for accuracy and antigen tests are a fast and inexpensive alternative. But backers of a third type of test, developed by a Nobel Prize winner [...]
COVID-19 is a severe infectious disease that has claimed >150,000 lives and infected millions in the United States thus far, especially the elderly population. Emerging evidence has shown the virus to cause hemorrhagic and immunologic [...]
Switzerland’s Covid-19 scientific taskforce chief says hospitals across the Alpine country could be swamped with new coronavirus cases in the next two or three weeks unless the situation improves. “We estimate that the capacity limit [...]
Scientists are to increase surveillance for new coronavirus mutations amid concerns that future strains of the virus could develop at least partial resistance to antibody treatments and Covid-19 vaccines. There is no evidence that the [...]